Ulvan lyase assisted structural characterization of ulvan from Ulva pertusa and its antiviral activity against vesicular stomatitis virus

Int J Biol Macromol. 2020 Aug 15:157:75-82. doi: 10.1016/j.ijbiomac.2020.04.187. Epub 2020 Apr 25.

Abstract

Marine green algae are valuable sources of diverse health-promoting bioactive components. Ulvan is suitable for biological applications due to its unique structure and numerous bioactivities. Here, the complex structure of ulvan from Ulva pertusa was analyzed using specific ulvan lyase degradation, MS, and NMR detection. Its structure mainly consists of →4)-β-d-GlcA-(1 → 4)-α-l-Rha3S-(1 → and →4)-β-d-Xyl-(1 → 4)-α-l-Rha3S-(1 → repeating units. Small amounts of →4)-α-l-IdoA-(1 → 4)-α-l-Rha3S-(1 → unit also exist. In addition, a minor number of branches, a single GlcA, and a long branch containing GlcA-Glc were linked to Rha3S. The antiviral activity of the ulvan and its degraded fragments were further investigated. Ulvan (1068.2 kDa) and ulvan-F1 (38.5 kDa) with relatively high molecular weight showed potency of inhibiting the infection and replication of vesicular stomatitis virus (VSV) at 100 μg/mL, the inhibition rate of VSV replication was 40.75% and 40.13%, respectively. These results indicated that ulvan has potential as a functional agent.

Keywords: Antiviral activity; Structure; Sulfated polysaccharide; Ulva pertusa; Ulvan lyase.

MeSH terms

  • Antiviral Agents / chemistry*
  • Antiviral Agents / metabolism
  • Antiviral Agents / pharmacology*
  • Carbohydrate Sequence
  • Molecular Weight
  • Polysaccharide-Lyases / metabolism*
  • Polysaccharides / chemistry*
  • Polysaccharides / metabolism
  • Polysaccharides / pharmacology*
  • Ulva / enzymology*
  • Vesiculovirus / drug effects*
  • Vesiculovirus / physiology
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • Polysaccharides
  • ulvan
  • Polysaccharide-Lyases
  • ulvan-lyase